SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1877NVS shakes up top management: Rummelt out, George in, as CEO of Sandoz. <imgDewDiligence_on_SI-10/20/2008
1876Teva files petition against generic Copaxone Teva (NASDAQ:TEVA) submitted a Citrkrw-10/2/2008
1875Bayer gets EU approval for anticlotting medicine Wednesday October 1, 3:02 pm ETtnsaf-10/1/2008
1874This discussion from 18 months ago (!) seems to be relevant to a recent thread: DewDiligence_on_SI-9/30/2008
1873<i>Seemed kind of 50:50 to me, the Momenta version only approved versus thDewDiligence_on_SI-9/30/2008
1872<i>>I take it you subscribe to "the FDA approves all 3 generics scDewDiligence_on_SI-9/30/2008
1871>>Probably 1Q09. If the FDA action is to approve, the precise timing doesntuck-9/30/2008
1870<i>This being the OGD, I gather there is no deadline for the FDA to Act. NDewDiligence_on_SI-9/29/2008
1869This being the OGD, I gather there is no deadline for the FDA to Act. No Class tuck-9/29/2008
186809:51 MNTA Momenta Pharma discloses its collaboration partner submitted to FDA IRWIN JAMES FRANKEL-9/26/2008
1867PETITIONS FOR REHEARING AND REHEARING EN BANC 2007-1280 AVENTIS PHARMA S.A., ET IRWIN JAMES FRANKEL-9/25/2008
1866Director James Sulat is no longer employed by MEMY. FWIWDewDiligence_on_SI-9/22/2008
1865I'm not sure who it will be up to. If a doc overwrites a script and says &qurkrw-9/22/2008
1864"I can't stand seeing this stock go down day by day. Any idea why? I haGo Market Go!-9/14/2008
1863But it really won't be up to you to decide, once the insurance companies putmopgcw-9/12/2008
1862>>Would you switch your wife (off copaxone, not literally) with no trial dIRWIN JAMES FRANKEL-9/12/2008
1861Would you switch your wife (off copaxone, not literally) with no trial data? Hrkrw-9/12/2008
1860>>he was incredibly impressed with how thorough teva is, sent a nurse out IRWIN JAMES FRANKEL19/12/2008
1859A friend of mine was just diagnosed and went on copaxone. Nothing you wouldn'rkrw-9/12/2008
1858SI down 170K to 5.7M But dtc up to 20 from 8. ijIRWIN JAMES FRANKEL-9/10/2008
1857BMY, PFE Report Tepid Phase-2 Results for Apixaban in ACS (news from 2-Sep-2008)DewDiligence_on_SI-9/9/2008
1856Buy Japanese pharmas?tom pope-9/3/2008
1855Here are the generic-substitution numbers for the world’s leading pharmaceuticalDewDiligence_on_SI-9/3/2008
1854Old news (see #1851) :-)DewDiligence_on_SI-9/3/2008
1853Bernhard Hampl "... we soon expect enoxaparin approval..." further: IRWIN JAMES FRANKEL-9/3/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News